Federated Hermes Inc. Trims Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Federated Hermes Inc. decreased its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 28.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,954 shares of the company’s stock after selling 14,216 shares during the quarter. Federated Hermes Inc. owned about 0.07% of Prestige Consumer Healthcare worth $2,140,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Trexquant Investment LP raised its position in Prestige Consumer Healthcare by 109.1% in the 3rd quarter. Trexquant Investment LP now owns 8,340 shares of the company’s stock valued at $477,000 after purchasing an additional 4,351 shares during the last quarter. Qube Research & Technologies Ltd raised its position in Prestige Consumer Healthcare by 91.4% during the 3rd quarter. Qube Research & Technologies Ltd now owns 72,092 shares of the company’s stock worth $4,123,000 after buying an additional 34,430 shares during the last quarter. SG Americas Securities LLC purchased a new position in Prestige Consumer Healthcare during the 3rd quarter worth $1,632,000. Connors Investor Services Inc. purchased a new position in Prestige Consumer Healthcare during the 3rd quarter worth $1,569,000. Finally, Hsbc Holdings PLC raised its position in Prestige Consumer Healthcare by 17.1% during the 3rd quarter. Hsbc Holdings PLC now owns 22,075 shares of the company’s stock worth $1,263,000 after buying an additional 3,226 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on PBH shares. TheStreet upgraded shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research report on Monday, February 12th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, February 10th. One research analyst has rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $110.00.

Prestige Consumer Healthcare Stock Performance

NYSE:PBH opened at $70.47 on Monday. The stock has a market cap of $3.50 billion, a PE ratio of -42.97, a price-to-earnings-growth ratio of 1.91 and a beta of 0.52. Prestige Consumer Healthcare Inc. has a fifty-two week low of $55.96 and a fifty-two week high of $75.31. The firm’s fifty day simple moving average is $70.93 and its 200-day simple moving average is $64.27. The company has a quick ratio of 1.92, a current ratio of 3.09 and a debt-to-equity ratio of 0.75.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, February 8th. The company reported $1.06 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.02. The firm had revenue of $282.74 million for the quarter, compared to analysts’ expectations of $280.25 million. Prestige Consumer Healthcare had a negative net margin of 7.11% and a positive return on equity of 14.09%. The firm’s revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.04 EPS. Analysts expect that Prestige Consumer Healthcare Inc. will post 4.33 earnings per share for the current fiscal year.

Insider Activity at Prestige Consumer Healthcare

In related news, SVP Mary Beth Fritz sold 5,336 shares of the stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $69.00, for a total value of $368,184.00. Following the sale, the senior vice president now directly owns 15,934 shares of the company’s stock, valued at approximately $1,099,446. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 1.60% of the stock is owned by corporate insiders.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.